Systemic-onset juvenile rheumatoid arthritis (Still's disease in children) involving multiple joint sites simultaneously, requiring both systemic features and multi-site joint documentation to support the code.
Verified May 8, 2026 · 6 sources ↓
- Status
- Billable
- Chapter
- 13
- Related CPT
- 9
- Region
- Multi-region
Documentation tips
What should appear in the chart to support M08.29.
Source · Editorial brief grounded in 6 cited references ↓
- Specify that joint involvement spans multiple named sites (e.g., bilateral knees, right wrist, and left ankle) — 'multiple joints' alone is insufficient; enumerate them.
- Document systemic onset features explicitly: quotidian fever pattern (daily high spikes returning to baseline) and evanescent salmon-colored rash are the clinical validators for the M08.2x subcategory.
- Record the patient's age or date of birth in the encounter note; this code is restricted to patients with onset before age 16, and adult-onset Still's disease requires M06.1 instead.
- If Crohn's disease or ulcerative colitis is a comorbidity, list it with its own code (K50.- or K51.-) per the 'Code also' instruction at the M08 category level.
- Note rheumatoid factor status and any biologic or csDMARD therapy in progress — this differentiates M08.2 (systemic onset) from M08.3 (seronegative polyarticular) and supports medical necessity for ongoing biologics.
- When ordering nerve conduction studies for peripheral neuropathy related to systemic JIA, CMS LCD A57478 lists M08.2A (other specified site) as a supporting diagnosis — confirm the site documentation matches the NCS order.
Related CPT procedures
Procedure codes commonly billed with M08.29. Linking the right diagnosis to the right procedure is what establishes medical necessity.
Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis
Common coding pitfalls
The recurring mistakes coders make with M08.29 and adjacent codes.
Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓
- Assigning M08.29 to an adult patient with Still's disease phenotype — adult-onset Still's disease is an Excludes1 condition coded to M06.1; M08.2x is strictly for pediatric onset.
- Using M08.29 when only one or two specific sites are involved — if laterality and a single joint region are clearly documented, use the site-specific M08.2x code (e.g., M08.211 right shoulder) rather than defaulting to 'multiple sites.'
- Defaulting to M08.20 (unspecified site) when the record names multiple joints — M08.29 is the correct choice when multiple named sites are documented; M08.20 is a last resort when site is genuinely not documented.
- Omitting secondary codes for documented associated conditions (Crohn's, UC) — the M08 category has an explicit 'Code also' instruction that auditors check.
- Confusing M08.29 (systemic onset, multiple sites) with M08.39 (seronegative polyarticular JRA, multiple sites) — systemic onset requires documented systemic features (fever, rash); polyarticular seronegative does not.
Clinical context
Source · Editorial summary grounded in 6 cited references ↓
M08.29 applies when a patient under 16 has documented systemic-onset juvenile rheumatoid arthritis — also known as Still's disease in children — with active involvement at multiple joint sites. Systemic onset means the clinical picture includes characteristic features such as a quotidian (daily spiking) fever pattern and evanescent salmon-colored rash, in addition to arthritis. 'Multiple sites' distinguishes this code from single-site laterality codes (e.g., M08.21 for the right shoulder, M08.22 for the left shoulder) and from M08.20, which is used when no specific site is documented.
The M08.2x family carries a critical Excludes1 note: adult-onset Still's disease maps to M06.1, not here. If your patient is an adult, this code is wrong regardless of phenotype. The parent category M08 also excludes psoriatic juvenile arthropathy (L40.54), juvenile dermatomyositis (M33.0-), Felty's syndrome (M05.0), and arthropathy in Whipple's disease (M14.8) — all require separate codes. If an associated condition such as Crohn's disease (K50.-) or ulcerative colitis (K51.-) is present, code it additionally per the 'Code also' instruction.
M08.29 groups into MS-DRG v43.0 categories 545 (connective tissue disorders with MCC), 546 (with CC), and 547 (without CC/MCC), so severity and complication documentation directly affects DRG assignment and reimbursement. In an orthopedic setting, this code most commonly appears when a pediatric patient presents with systemic JIA involving knees, ankles, wrists, and other joints concurrently — often in the context of surgical planning, joint aspiration, or orthotics referral.
Sibling codes
Other billable codes under M08.2 (laterality / anatomic variants).
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 6 cited references ↓
01What distinguishes M08.29 from M08.20?
02Can M08.29 be used for an adult patient diagnosed with Still's disease as a child?
03Does M08.29 require a positive rheumatoid factor for coding?
04Should I code associated Crohn's disease separately when using M08.29?
05Which MS-DRGs does M08.29 map to?
06Is M08.29 appropriate for an orthopedic encounter, or only for rheumatology?
07What is the Excludes1 note at M08.2 and why does it matter?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CDC ICD-10-CM Tabular List 2026 (effective Oct 1, 2025)
- 02icd10data.comhttps://www.icd10data.com/ICD10CM/Codes/M00-M99/M05-M14/M08-/M08.29
- 03aapc.comhttps://www.aapc.com/codes/icd-10-codes/M08.29
- 04cms.govhttps://www.cms.gov/medicare-coverage-database/view/article.aspx?articleid=57478&ver=35
- 05icdcodes.aihttps://icdcodes.ai/diagnosis/juvenile-rheumatoid-arthritis/documentation
- 06pmc.ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10161784/
Mira AI Scribe
Mira AI Scribe captures the joint inventory (each named site affected), the systemic feature pattern (fever spike timing, rash description), patient age, RF/ANA lab results, and current DMARD or biologic regimen from the encounter note. This prevents downstream downcoding to M08.20 (unspecified site), audit risk from missing systemic-onset justification, and DRG miscalculation when comorbidities like IBD go uncoded.
See how Mira captures M08.29 documentation